Tag | Content |
---|
EnhancerAtlas ID | HS078-10998 | Organism | Homo sapiens | Tissue/cell | H2171 | Coordinate | chr20:61702970-61704060 | TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
KLF5 | MA0599.1 | chr20:61703181-61703191 | GCCCCGCCCC | + | 6.02 | KLF5 | MA0599.1 | chr20:61703388-61703398 | GCCCCGCCCC | + | 6.02 | KLF5 | MA0599.1 | chr20:61703403-61703413 | GCCCCGCCCC | + | 6.02 | SP2 | MA0516.2 | chr20:61703384-61703401 | CTCAGCCCCGCCCCTCG | + | 6.05 | SP2 | MA0516.2 | chr20:61703177-61703194 | ACAAGCCCCGCCCCATA | + | 6.31 |
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
| Enhancer Sequence | GTTCAGAGCC CACCCCACTG GAAGTACAGG AGACTGAGTC AGAGGCCAGT CAGGCCGGAT 60 GAGATCAACA GTGATTTGCC TCCAAGCCCT GATTCCTCCC TGAGGAATGC TCCTGAGAAA 120 ACGCTGGCTC CCACTCACAG CTGGAGCTTC AAAGGTTGGT CTAGCACTGA CCGTGTGGAC 180 CCACGTGCTT CTGTCTGGAA AAGCCCCACA AGCCCCGCCC CATAAGACCC CGCCCCTCTT 240 AGCTCCGCCC ACAAGGCCAC TTCCCAGCTC CGCCCATCTC GCGTCTGTAC CCTACAGGCT 300 CTGCCTGGTT CCACCCCACC GCTTCTGCCA CCCACTCTAA GGACCCGCTC CTCCCCGCCC 360 CCGCCCCCAA AGCCGCTCCT CTCACGGCCC CCGACCCCGC AGGCACCGAC TGTTCTCAGC 420 CCCGCCCCTC GAGGCCCCGC CCCGCGGCTT CCCGCCGGGG ATTGCGGCTG CGCCTCTGAC 480 CCTCCGCTCC GGGCTCCGGG CTCAGGTCCC ACACCTGCCC GCGCCCCCAG GCCCCGCCGT 540 CCCCCAGAGC CTGCAGCGGG CGCCGCGCAG GCCGCCGGGC TCCTCCGGGT GGGCCGGGCT 600 CGGGCTTTTG GAGCCGCGCG CCCACCGACC CCTCCCACGG GCGGCGGGGG GAGAGCCCAC 660 CCAGAGGCGC AGCGGGGCCG GTGGTGTTTC CCGCCCTCCC AGGGGGCCGC GGGTCCGGGG 720 GCAGCAGCGG GGCGCGGGGC GGAGGGAGGC CCGGCGGGAA CGGGCGCCCC CTTTGCACCC 780 ACAGCCGTGG AACGCCGAGG TCTCAGCTCC CCTACGGCGC GCGCCCCGAG ACCCCGCAAG 840 GGCAGTGCTG GGGACGCGGG GCCGAGACTC GAGGACGCCC GAGGCCGGGA CGGGGTGTGG 900 GGGCGTCCCC CAGGCTCCCG GGTCCCAGTG CAGGGGCTCG CGGTCAGGAG GTTAGGTGGA 960 TGAGTGAAGG GGAAAAGCGC GGTTCTAGCT GCCTGCTCAG GCTTGGGGCG ATGTGAACGT 1020 CGGGGTTTGC CCCTCGACCC CCCACCAGAA CGCAGATACT TCTCAGCAAA GAGGAGCTTG 1080 GGGCAGCCCA 1090
|
| |
|
|
|